AMH Equity Ltd Takes $703,000 Position in Aspen Aerogels, Inc. (NYSE:ASPN)

AMH Equity Ltd bought a new stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN) in the 1st quarter, Holdings Channel reports. The firm bought 110,000 shares of the construction company’s stock, valued at approximately $703,000.

Several other large investors have also recently made changes to their positions in ASPN. Rice Hall James & Associates LLC lifted its stake in shares of Aspen Aerogels by 49.5% in the first quarter. Rice Hall James & Associates LLC now owns 828,789 shares of the construction company’s stock worth $5,296,000 after buying an additional 274,587 shares in the last quarter. CWM LLC lifted its stake in shares of Aspen Aerogels by 2,137.9% in the first quarter. CWM LLC now owns 8,325 shares of the construction company’s stock worth $53,000 after buying an additional 7,953 shares in the last quarter. New York State Common Retirement Fund lifted its stake in shares of Aspen Aerogels by 2,073.6% in the first quarter. New York State Common Retirement Fund now owns 437,572 shares of the construction company’s stock worth $2,796,000 after buying an additional 417,441 shares in the last quarter. Alps Advisors Inc. lifted its stake in shares of Aspen Aerogels by 1.7% in the first quarter. Alps Advisors Inc. now owns 126,326 shares of the construction company’s stock worth $807,000 after buying an additional 2,093 shares in the last quarter. Finally, Envestnet Asset Management Inc. lifted its stake in shares of Aspen Aerogels by 17.5% in the first quarter. Envestnet Asset Management Inc. now owns 55,511 shares of the construction company’s stock worth $355,000 after buying an additional 8,249 shares in the last quarter. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Aspen Aerogels news, CEO Donald R. Young bought 20,000 shares of Aspen Aerogels stock in a transaction on Monday, May 12th. The stock was acquired at an average cost of $5.35 per share, with a total value of $107,000.00. Following the completion of the acquisition, the chief executive officer owned 550,856 shares in the company, valued at approximately $2,947,079.60. This represents a 3.77% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 4.30% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the stock. Oppenheimer downgraded shares of Aspen Aerogels from an “outperform” rating to a “market perform” rating in a research note on Thursday, May 8th. Barclays reiterated an “equal weight” rating and issued a $7.00 target price (down previously from $13.00) on shares of Aspen Aerogels in a research note on Thursday, May 29th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, seven have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $18.44.

Aspen Aerogels Stock Up 8.6%

Shares of Aspen Aerogels stock opened at $7.23 on Friday. The company has a market cap of $593.66 million, a price-to-earnings ratio of -2.07 and a beta of 2.65. The company’s 50 day moving average is $6.22 and its 200 day moving average is $7.60. Aspen Aerogels, Inc. has a twelve month low of $4.16 and a twelve month high of $33.15. The company has a quick ratio of 3.53, a current ratio of 4.22 and a debt-to-equity ratio of 0.40.

Aspen Aerogels (NYSE:ASPN) last announced its earnings results on Thursday, May 8th. The construction company reported ($0.06) EPS for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.01. Aspen Aerogels had a negative net margin of 65.47% and a positive return on equity of 6.69%. The business had revenue of $78.72 million during the quarter, compared to analysts’ expectations of $82.75 million. During the same period in the prior year, the company earned ($0.02) earnings per share. The firm’s revenue was down 16.7% on a year-over-year basis. Research analysts anticipate that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.